GlassScriptPhysician profile
Roy J Bardwell
NPI 1154562080
$7,997.33
in general payments reported to CMS, 2019-2025
44 companies · $861 in 2025
The $861 reported for 2025 was more than what 83% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,388 · 2020: $1,245 · 2021: $1,546 · 2022: $1,389 · 2023: $958 · 2024: $611 · 2025: $861.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,430.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,430.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,402.79 | 2020-2025 | Vraylar, Qulipta, Ubrelvy |
| Astrazeneca Pharmaceuticals LP | $1,139.71 | 2019-2025 | Breztri, Airsupra, Farxiga |
| Novo Nordisk INC | $1,009.60 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $631.11 | 2019-2025 | |
| Lilly USA, LLC | $522.26 | 2019-2025 | Mounjaro, Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $417.91 | 2019-2022 | |
| Allergan, INC. | $400.79 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $285.60 | 2021-2024 | Xarelto |
| Indivior INC. | $239.05 | 2019-2025 | Sublocade |
| Bayer Healthcare Pharmaceuticals INC. | $231.72 | 2021-2024 | |
| Orexo US, INC. | $156.34 | 2019-2024 | Zubsolv |
| Abbott Laboratories | $138.84 | 2022-2023 | Freestyle Libre 3 |
| Collegium Pharmaceutical, INC. | $136.06 | 2019-2025 | Belbuca |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $135.15 | 2019-2024 | Relistor, Xifaxan |
| Amgen INC. | $131.37 | 2020-2022 |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roy Bardwell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.